General InformationCambrian BioPharma is a California-based longevity biotech company founded in 2021 with 11-50 employees focused on cellular reprogramming therapies to reverse aging.
Funding & FinancialsThe company has raised Series A funding to support development of its epigenetic reprogramming platform, with backing from prominent longevity and biotech investors.
Leadership & TeamThe company was founded by longevity researchers and biotech entrepreneurs focused on cellular rejuvenation and anti-aging therapeutics.
Recent ActivityCambrian BioPharma is actively developing its cellular reprogramming pipeline using AI-driven approaches to identify novel aging reversal interventions and has been advancing preclinical programs.